CD40 mutant expression and its clinical significance to prognosis in gastric cancer patients

Table 1 Association between gastric cancer patients’ clinicopathological characteristics s and CD40 mutant levels in tumor tissues (n = 78)

Characteristics	Cases	CD40 mutant expression		χ ²	P
Characteristics	Cases	Positive	Negative	χ ²	P
Sex
Male	58	33	25	0.286	0.593
Female	20	10	10	0.286	0.593
Age (years)
≥60	48	36	12	2.849	0.091
<60	30	17	13	2.849	0.091
Tumor size (cm)
≥5	37	20	17	0.033	0.856
<5	41	23	18	0.033	0.856
Differentiation
Well/moderate	43	20	23	2.074	0.15
Poor	35	22	13	2.074	0.15
Depth of tumor invasion
Not to deep muscle layer	10	1	9	9.444	0.002^a
Deep muscle layer	68	42	26	9.444	0.002^a
Lymph nodes metastasis
Yes	60	39	21	7.802	0.005^a
No	18	5	13	7.802	0.005^a
TNM stage
I and II	17	4	13	8.774	0.003^a
III and IV	61	39	22	8.774	0.003^a

ISSN: 1477-7819